Listed

Xeris Biopharma Holdings, Inc.

XERSNasdaqCIK 1867096HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$92.1m, Q2 FY2026
Operating income$5.2m, Q2 FY2026
Net income−$31.1m, Q2 FY2026
Xeris Biopharma Holdings, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q4 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m48.3Revenue, Q3 FY2023, three months to 2023-09-30$48.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure44.4Revenue, Q4 FY2023, three months to 2023-12-31$44.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure40.6Revenue, Q4 FY2024, three months to 2024-03-31$40.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure48.1Revenue, Q2 FY2024, three months to 2024-06-30$48.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure54.3Revenue, Q3 FY2024, three months to 2024-09-30$54.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure60.1Revenue, Q4 FY2024, three months to 2024-12-31$60.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure60.1Revenue, Q1 FY2025, three months to 2025-03-31$60.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure71.5Revenue, Q2 FY2025, three months to 2025-06-30$71.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure74.4Revenue, Q3 FY2025, three months to 2025-09-30$74.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure85.8Revenue, Q4 FY2025, three months to 2025-12-31$85.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure83.1Revenue, Q1 FY2026, three months to 2026-03-31$83.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure92.1Revenue, Q2 FY2026, three months to 2026-06-30$92.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m5.0Research and development, Q3 FY2023, three months to 2023-09-30$5.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure6.4Research and development, Q4 FY2023, three months to 2023-12-31$6.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure7.8Research and development, Q4 FY2024, three months to 2024-03-31$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure5.8Research and development, Q2 FY2024, three months to 2024-06-30$5.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure5.9Research and development, Q3 FY2024, three months to 2024-09-30$5.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure6.1Research and development, Q4 FY2024, three months to 2024-12-31$6.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure7.8Research and development, Q1 FY2025, three months to 2025-03-31$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure8.1Research and development, Q2 FY2025, three months to 2025-06-30$8.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure7.5Research and development, Q3 FY2025, three months to 2025-09-30$7.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure7.9Research and development, Q4 FY2025, three months to 2025-12-31$7.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure8.8Research and development, Q1 FY2026, three months to 2026-03-31$8.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure10.7Research and development, Q2 FY2026, three months to 2026-06-30$10.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Selling, general and administrative$m37.3Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$37.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure37.6Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$37.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure38.4Selling, general and administrative, Q4 FY2024, three months to 2024-03-31$38.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure40.0Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$40.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure45.0Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$45.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure40.1Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$40.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure44.0Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$44.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure44.4Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$44.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure46.5Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$46.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure47.5Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$47.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure53.1Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$53.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure61.0Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$61.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Operating income$m(4.9)Operating income, Q3 FY2023, three months to 2023-09-30−$4.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure(9.8)Operating income, Q4 FY2023, three months to 2023-12-31−$9.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure(14.2)Operating income, Q4 FY2024, three months to 2024-03-31−$14.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure(8.2)Operating income, Q2 FY2024, three months to 2024-06-30−$8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure(12.9)Operating income, Q3 FY2024, three months to 2024-09-30−$12.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure1.7Operating income, Q4 FY2024, three months to 2024-12-31$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure(3.1)Operating income, Q1 FY2025, three months to 2025-03-31−$3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure4.5Operating income, Q2 FY2025, three months to 2025-06-30$4.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure6.7Operating income, Q3 FY2025, three months to 2025-09-30$6.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure16.8Operating income, Q4 FY2025, three months to 2025-12-31$16.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure7.9Operating income, Q1 FY2026, three months to 2026-03-31$7.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure5.2Operating income, Q2 FY2026, three months to 2026-06-30$5.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Interest expense$m6.8Interest expense, Q3 FY2023, three months to 2023-09-30$6.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-09, accession 0001867096-23-000139.Report this figure7.0Interest expense, Q4 FY2023, three months to 2023-12-31$7.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-06, accession 0001867096-24-000031. Derived: 12-month figure less the 9-month figure.Report this figure7.0Interest expense, Q4 FY2024, three months to 2024-03-31$7.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0001867096-24-000065.Report this figure8.0Interest expense, Q2 FY2024, three months to 2024-06-30$8.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure7.8Interest expense, Q3 FY2024, three months to 2024-09-30$7.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure7.7Interest expense, Q4 FY2024, three months to 2024-12-31$7.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure7.3Interest expense, Q1 FY2025, three months to 2025-03-31$7.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure7.4Interest expense, Q2 FY2025, three months to 2025-06-30$7.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure7.3Interest expense, Q3 FY2025, three months to 2025-09-30$7.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure7.2Interest expense, Q4 FY2025, three months to 2025-12-31$7.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure6.9Interest expense, Q1 FY2026, three months to 2026-03-31$6.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure6.9Interest expense, Q2 FY2026, three months to 2026-06-30$6.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Income tax$m(0.3)Income tax, Q3 FY2023, three months to 2023-09-30−$338.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure(0.2)Income tax, Q4 FY2023, three months to 2023-12-31−$236.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure0.3Income tax, Q4 FY2024, three months to 2024-03-31$307.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure0.7Income tax, Q2 FY2024, three months to 2024-06-30$749.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure(3.3)Income tax, Q3 FY2024, three months to 2024-09-30−$3.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Net income$m(12.2)Net income, Q3 FY2023, three months to 2023-09-30−$12.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure(13.4)Net income, Q4 FY2023, three months to 2023-12-31−$13.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure(19.0)Net income, Q4 FY2024, three months to 2024-03-31−$19.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure(15.0)Net income, Q2 FY2024, three months to 2024-06-30−$15.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure(15.7)Net income, Q3 FY2024, three months to 2024-09-30−$15.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure(5.1)Net income, Q4 FY2024, three months to 2024-12-31−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure(9.2)Net income, Q1 FY2025, three months to 2025-03-31−$9.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure(1.9)Net income, Q2 FY2025, three months to 2025-06-30−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure0.6Net income, Q3 FY2025, three months to 2025-09-30$621.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure11.1Net income, Q4 FY2025, three months to 2025-12-31$11.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure2.2Net income, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure(31.1)Net income, Q2 FY2026, three months to 2026-06-30−$31.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Diluted EPS$ per share(0.09)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figurenot reported(0.14)Diluted EPS, Q4 FY2024, three months to 2024-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure(0.10)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure(0.11)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figurenot reported(0.06)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure(0.01)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure0.00Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figurenot reported0.01Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure(0.18)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Basic EPS$ per share(0.09)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figurenot reported(0.14)Basic EPS, Q4 FY2024, three months to 2024-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure(0.10)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure(0.11)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figurenot reported(0.06)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure(0.01)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure0.00Basic EPS, Q3 FY2025, three months to 2025-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figurenot reported0.01Basic EPS, Q1 FY2026, three months to 2026-03-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure(0.18)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure

Balance sheet

Cash and equivalents$121.7m, Q2 FY2026
Long-term debt$188.8m, Q2 FY2026
Shareholders' equity−$9.7m, Q2 FY2026
Xeris Biopharma Holdings, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m46.1Cash and equivalents, Q3 FY2023, at 2023-09-30$46.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure67.4Cash and equivalents, FY2023, at 2023-12-31$67.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-02, accession 0001867096-26-000016.Report this figure62.7Cash and equivalents, FY2024, at 2024-03-31$62.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure57.6Cash and equivalents, Q2 FY2024, at 2024-06-30$57.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure59.2Cash and equivalents, Q3 FY2024, at 2024-09-30$59.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure71.6Cash and equivalents, FY2024, at 2024-12-31$71.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-02, accession 0001867096-26-000016.Report this figure58.4Cash and equivalents, Q1 FY2025, at 2025-03-31$58.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure59.3Cash and equivalents, Q2 FY2025, at 2025-06-30$59.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure91.6Cash and equivalents, Q3 FY2025, at 2025-09-30$91.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure111Cash and equivalents, FY2025, at 2025-12-31$111.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure112Cash and equivalents, Q1 FY2026, at 2026-03-31$111.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure122Cash and equivalents, Q2 FY2026, at 2026-06-30$121.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Current assets$m158Current assets, Q3 FY2023, at 2023-09-30$158.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001867096-23-000139.Report this figure156Current assets, FY2023, at 2023-12-31$156.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-06, accession 0001867096-25-000039.Report this figure173Current assets, FY2024, at 2024-03-31$173.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001867096-24-000065.Report this figure170Current assets, Q2 FY2024, at 2024-06-30$170.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001867096-24-000162.Report this figure163Current assets, Q3 FY2024, at 2024-09-30$162.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure168Current assets, FY2024, at 2024-12-31$167.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-02, accession 0001867096-26-000016.Report this figure163Current assets, Q1 FY2025, at 2025-03-31$163.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure186Current assets, Q2 FY2025, at 2025-06-30$185.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure224Current assets, Q3 FY2025, at 2025-09-30$224.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure240Current assets, FY2025, at 2025-12-31$240.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure252Current assets, Q1 FY2026, at 2026-03-31$251.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure275Current assets, Q2 FY2026, at 2026-06-30$274.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Total assets$m328Total assets, Q3 FY2023, at 2023-09-30$327.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001867096-23-000139.Report this figure323Total assets, FY2023, at 2023-12-31$322.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-06, accession 0001867096-25-000039.Report this figure337Total assets, FY2024, at 2024-03-31$336.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001867096-24-000065.Report this figure332Total assets, Q2 FY2024, at 2024-06-30$331.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001867096-24-000162.Report this figure321Total assets, Q3 FY2024, at 2024-09-30$321.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure323Total assets, FY2024, at 2024-12-31$323.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-02, accession 0001867096-26-000016.Report this figure315Total assets, Q1 FY2025, at 2025-03-31$315.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure335Total assets, Q2 FY2025, at 2025-06-30$334.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure370Total assets, Q3 FY2025, at 2025-09-30$370.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure384Total assets, FY2025, at 2025-12-31$383.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure392Total assets, Q1 FY2026, at 2026-03-31$392.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure412Total assets, Q2 FY2026, at 2026-06-30$411.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Current liabilities$m87.0Current liabilities, Q3 FY2023, at 2023-09-30$87.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001867096-23-000139.Report this figure95.2Current liabilities, FY2023, at 2023-12-31$95.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-06, accession 0001867096-25-000039.Report this figure73.1Current liabilities, FY2024, at 2024-03-31$73.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001867096-24-000065.Report this figure75.5Current liabilities, Q2 FY2024, at 2024-06-30$75.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001867096-24-000162.Report this figure91.0Current liabilities, Q3 FY2024, at 2024-09-30$91.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure100Current liabilities, FY2024, at 2024-12-31$100.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-02, accession 0001867096-26-000016.Report this figure95.1Current liabilities, Q1 FY2025, at 2025-03-31$95.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure95.2Current liabilities, Q2 FY2025, at 2025-06-30$95.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure116Current liabilities, Q3 FY2025, at 2025-09-30$116.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure110Current liabilities, FY2025, at 2025-12-31$109.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure119Current liabilities, Q1 FY2026, at 2026-03-31$118.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure190Current liabilities, Q2 FY2026, at 2026-06-30$189.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Total liabilities$m324Total liabilities, Q3 FY2023, at 2023-09-30$323.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001867096-23-000139.Report this figure329Total liabilities, FY2023, at 2023-12-31$329.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-06, accession 0001867096-25-000039.Report this figure346Total liabilities, FY2024, at 2024-03-31$345.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001867096-24-000065.Report this figure351Total liabilities, Q2 FY2024, at 2024-06-30$351.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001867096-24-000162.Report this figure349Total liabilities, Q3 FY2024, at 2024-09-30$349.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure353Total liabilities, FY2024, at 2024-12-31$352.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-02, accession 0001867096-26-000016.Report this figure351Total liabilities, Q1 FY2025, at 2025-03-31$350.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure354Total liabilities, Q2 FY2025, at 2025-06-30$354.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure371Total liabilities, Q3 FY2025, at 2025-09-30$371.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure370Total liabilities, FY2025, at 2025-12-31$369.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure379Total liabilities, Q1 FY2026, at 2026-03-31$379.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure422Total liabilities, Q2 FY2026, at 2026-06-30$421.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Long-term debt$m190Long-term debt, Q3 FY2023, at 2023-09-30$190.4m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-09, accession 0001867096-23-000139.Report this figure191Long-term debt, FY2023, at 2023-12-31$190.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-06, accession 0001867096-25-000039.Report this figure230Long-term debt, FY2024, at 2024-03-31$229.7m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-09, accession 0001867096-24-000065.Report this figure230Long-term debt, Q2 FY2024, at 2024-06-30$230.5m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-08, accession 0001867096-24-000162.Report this figure216Long-term debt, Q3 FY2024, at 2024-09-30$216.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure217Long-term debt, FY2024, at 2024-12-31$217.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-02, accession 0001867096-26-000016.Report this figure218Long-term debt, Q1 FY2025, at 2025-03-31$217.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure219Long-term debt, Q2 FY2025, at 2025-06-30$218.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure219Long-term debt, Q3 FY2025, at 2025-09-30$219.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure220Long-term debt, FY2025, at 2025-12-31$220.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure221Long-term debt, Q1 FY2026, at 2026-03-31$221.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure189Long-term debt, Q2 FY2026, at 2026-06-30$188.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Current portion of debt$mnot reported0.0Current portion of debt, FY2023, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-06, accession 0001867096-25-000039.Report this figurenot reportednot reported15.1Current portion of debt, Q3 FY2024, at 2024-09-30$15.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure15.1Current portion of debt, FY2024, at 2024-12-31$15.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-02, accession 0001867096-26-000016.Report this figure12.0Current portion of debt, Q1 FY2025, at 2025-03-31$12.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure0.0Current portion of debt, Q2 FY2025, at 2025-06-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure0.0Current portion of debt, Q3 FY2025, at 2025-09-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figurenot reported63.8Current portion of debt, Q2 FY2026, at 2026-06-30$63.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure
Shareholders' equity$m3.9Shareholders' equity, Q3 FY2023, at 2023-09-30$3.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure(6.8)Shareholders' equity, FY2023, at 2023-12-31−$6.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-02, accession 0001867096-26-000016.Report this figure(9.2)Shareholders' equity, FY2024, at 2024-03-31−$9.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure(19.3)Shareholders' equity, Q2 FY2024, at 2024-06-30−$19.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure(28.3)Shareholders' equity, Q3 FY2024, at 2024-09-30−$28.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure(29.6)Shareholders' equity, FY2024, at 2024-12-31−$29.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure(35.1)Shareholders' equity, Q1 FY2025, at 2025-03-31−$35.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure(19.3)Shareholders' equity, Q2 FY2025, at 2025-06-30−$19.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure(0.9)Shareholders' equity, Q3 FY2025, at 2025-09-30−$861.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure13.7Shareholders' equity, FY2025, at 2025-12-31$13.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure13.0Shareholders' equity, Q1 FY2026, at 2026-03-31$13.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure(9.7)Shareholders' equity, Q2 FY2026, at 2026-06-30−$9.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure

Cash flow

Operating cash flow$8.3m, Q2 FY2026
Xeris Biopharma Holdings, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q4 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(14.6)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$14.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-08, accession 0001867096-24-000187. Derived: 9-month figure less the 6-month figure.Report this figure7.5Operating cash flow, Q4 FY2023, three months to 2023-12-31$7.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure(20.3)Operating cash flow, Q4 FY2024, three months to 2024-03-31−$20.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure(10.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$10.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001867096-25-000136. Derived: 6-month figure less the 3-month figure.Report this figure(8.3)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001867096-25-000159. Derived: 9-month figure less the 6-month figure.Report this figure2.0Operating cash flow, Q4 FY2024, three months to 2024-12-31$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure(10.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$10.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure0.2Operating cash flow, Q2 FY2025, three months to 2025-06-30$182.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001867096-26-000065. Derived: 6-month figure less the 3-month figure.Report this figure18.4Operating cash flow, Q3 FY2025, three months to 2025-09-30$18.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001867096-25-000159. Derived: 9-month figure less the 6-month figure.Report this figure20.0Operating cash flow, Q4 FY2025, three months to 2025-12-31$20.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001867096-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure9.9Operating cash flow, Q1 FY2026, three months to 2026-03-31$9.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure8.3Operating cash flow, Q2 FY2026, three months to 2026-06-30$8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001867096-26-000065. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)172.82m, Q2 FY2026
Xeris Biopharma Holdings, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q4 FY20232023-03-31Q4 FY20232023-06-30Q3 FY20232023-09-30Q4 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares136Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30135,951,761 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001867096-23-000139.Report this figure137Diluted shares (weighted), Q4 FY2023, three months to 2023-03-31137,142,565 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001867096-24-000065.Report this figure137Diluted shares (weighted), Q4 FY2023, three months to 2023-06-30137,338,071 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001867096-24-000162.Report this figure138Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30138,059,781 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-08, accession 0001867096-24-000187.Report this figure141Diluted shares (weighted), Q4 FY2024, three months to 2024-03-31140,513,907 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001867096-25-000089.Report this figure148Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30148,345,549 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001867096-25-000136.Report this figure149Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30148,993,823 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure152Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31152,445,935 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure159Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30159,459,413 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure178Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30177,617,307 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001867096-25-000159.Report this figure178Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31177,631,154 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001867096-26-000030.Report this figure173Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30172,823,455 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure

Shares outstanding: 182.32mShares outstanding, period not labelled, at 2026-07-31182,320,306 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001867096-26-000065.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.